Notes
Gen er a l Glycosyla tion P r oced u r e. Syn th esis of 9-(5-O-
J . Org. Chem., Vol. 64, No. 4, 1999 1379
mmol) and AIBN (5 mg, 0.03 mmol) were added to a solution of
nucleoside (0.08 mmol) in dry toluene (2 mL) and refluxed for 1
h. After the evaporation the residue was chromatographed using
MPLC by elution with a linear gradient of EtOAc in hexane.
Ben zyl-2,3-d id eoxy-3-flu or o-2-p h en ylselen en yl-r,â-D-r ibo-
fu r a n osyl)-6-ch lor op u r in e (11r, 11â) a n d 7-(5-O-Ben zyl-2,3-
d id eoxy-3-flu or o-2-p h en ylselen en yl-r,â-D-r ibofu r a n osyl)-
6-ch lor op u r in e (12r a n d 12â). 6-Chloropurine (59 mg, 0.38
mmol), Ph3P (79 mg, 0.3 mmol), DMF (2.5 mL), and DEAD (52
mg, 0.3 mmol) were added under vigorous stirring to a mixture
of 9 (76 mg, 0.2 mmol) which had been predried at 40 °C in an
oil pump vacuum. After the reaction was complete (5 min), the
reaction mixture was diluted with EtOAc (25 mL) and washed
with H2O (3 × 10 mL).The combined H2O extracts were washed
with EtOAc (10 mL), and the organic extracts were combined,
dried, and evaporated to dryness. The residue was chromato-
graphed using MPLC with a linear EtOAc gradient in hexane
(0-75% v/v) to obtain 82 mg (81%) of 11R,â and 12R,â (see Table
1). The nucleosides were eluted in the following order: 11â, 11R,
12â, and 12R.
9-(5-O-Ben zyl-2,3-d id eoxy-3-flu or o-â-D-r ibofu r a n osyl)-6-
ch lor op u r in e (14). Starting from 86.3 mg (0.167 mmol) of 11â
the general procedure of reduction was followed [chromatogra-
phy: linear gradient of EtOAc in hexane (0-70% v/v, V ) 0.6
L)] to obtain 55 mg (94%) of 14: Rf 0.42 (C); [R]21 -42.1° (c )
D
1.15, CHCl3); 1H NMR δ 8.70 (s, 1H), 8.46 (s, 1H), 7.40-7.22
(m, 5H), 6.65 (t, 1H, J ) 7.5), 5.39 (dt, 1H, J ) 55, 2.7, 2.7), 4.60
(d, 1H, J ) 11.7), 4.53 (ddd, 1H, J ) 26, 3, 3), 4.52 (d, 1H, J )
11.7), 3.77 (ddd, 1H, J ) 10, 3, 1.5), 3.71 (dd, 1H, J ) 10, 2.7),
2.90-2.65 (m, 2H); 13C NMR δ 152.1, 143.6, 136.8, 128.7, 128.3,
128.0, 94.9 (d, J ) 177.53), 84.8, 84.76 (d, J ) 25.05), 73.9, 69.6
(d, J ) 11.4), 39.7 (d, J ) 21.6); 19F NMR δ -176.5 (m). Anal.
Calcd for C17H16N4O2FCl: C, 57.76; H, 4.40; N, 14.76. Found:
C, 57.58; H, 4.30; N, 15.00.
11â: Rf 0.59 (C); mp 110-111 °C (EtOH); [R]25 -11.03° (c )
D
0.29, CHCl3); 1H NMR δ 8.57 (s, 1H), 8.09 (s, 1H), 7.40-6.82
(m, 10H), 6.52 (d, 1H, J ) 9.5), 5.41 (dd, 1H, J ) 53.2, 4.1), 4.67-
4.41 (m, 4H), 3.82 (ddd, 1H, J ) 10.6, 3.5, 1.3), 3.76 (dd, 1H, J
) 10.6, 3.1); 13C NMR δ 151.7, 143.5, 136.9, 134.3, 128.7, 128.6,
128.2, 127.7, 95.5 (d, J ) 179.7), 90.4, 83.4 (d, J ) 24.9), 73.8,
69.4 (d, J ) 11.3), 47.6 (d, J ) 20.0); 19F NMR δ -179.5 (dddJ
) 54.1, 37.3, 26.3). Anal. Calcd for C23H20N4O2SeFCl: C, 53.35;
H, 3.89; N, 10.82. Found: C, 53.55; H, 4.02; N, 10.81.
1-(5-O-Ben zyl-2,3-d id eoxy-3-flu or o-â-D-r ib ofu r a n osyl)-
th ym in e (15â) a n d 1-(5-O-Ben zyl-2,3-d id eoxy-3-flu or o-r-D-
r ibofu r a n osyl)th ym in e (15r). Starting from 46.8 mg (0.079
mM) of 13 the general procedure of reduction was used. The
reaction crude obtained was treated with a mixture of EtOH-
30% NH4OH (1:1 v/v, 2 mL) for 12 h. Then, the reaction mixture
was evaporated to dryness, coevaporated with the mixture of
toluene-EtOH (1:1 v/v, 4 × 5 mL), and chromatographed (0-
50% v/v, V ) 0.5 L) to give 7.0 mg (27.5%) of 15â and 8.3 mg
(32%) of 15R.
15â: Rf 0.23 (C); 1H NMR δ 8.38 (br s, 1H), 7.57 (s, 1H, H-6),
7.39-7.23 (m, 5H), 6.49 (dd, 1H, J ) 9.3, 5.7), 5.29 (dd, 1H, J )
53.7, 4.8), 4.60 (s, 2H), 4.41 (bd, 1H, J ) 27.9), 3.83 (dt, 1H, J )
10.8, 1.8, 1.8), 3.73 (dd, 1H, J ) 10.8, 2.1), 2.58 (ddd, 1H, J )
20.4, 14.7, 1.0), 2.19 (m, 1H, J ) 40.2, 14.7, 9.3, 4.5), 1.63 (s,
3H); 13C NMR δ 137.1, 135.6, 128.8, 128.4, 127.6, 94.9 (d, J )
177.6), 86.6, 84.0 (d, J ) 25.1), 73.7, 70.1 (d, J ) 11.4), 38.6 (d,
C-2′, J ) 20.5), 12.1 (s, Me-5); 19F NMR δ -175.5 (ddd, J ) 54,
41.5, 27, 22).
15r: Rf 0.18 (C); 1H NMR δ 8.60 (br s, 1H), 7.39-7.23 (m,
6H), 6.39 (dd, 1H, J ) 7.8, 1.8), 5.26 (dd, 1H, J ) 54.0, 4.8),
4.71 (dm, 1H, J ) 23.4, 4.2, 3.3), 4,58 (d, 1H, J ) 13.2), 4,50 (d,
1H, J ) 13.2), 3.59 (dd, 1H, J ) 10.5, 3.3), 3.53 (ddd, 1H, J )
10.5, 4.2, 1.8), 2.82 (dddd, 1H, J ) 40.8, 15.6, 7.8, 4.8), 2.29 (dd,
1H, J ) 24.9, 15.6), 1.94 (s, 3H); 13C NMR δ 137.3, 135.5, 128.7,
128.1, 127.72, 94.6 (d, J ) 175.28), 86.6, 86.0 (d, J ) 22.8), 73.7,
69.8 (d, J ) 11.4), 39.7 (d, J ) 20.5), 12.6.
11r: Rf 0.5 (C); mp 97-98 °C (EtOH); [R]25 +141.02° (c )
D
1.17, CHCl3); 1H NMR δ 8.68 (s, 1H), 8.4 (s, 1H), 7.35-7.25 (m,
10H), 6.89 (d, 1H, J ) 7.5), 5.38 (dd, 1H, J ) 54.1, 4.5), 4.87 (dt,
1H, J ) 23.6, 2.8, 2.8), 4.59 (d, 1H, J ) 11.8), 4.51 (d, 1H, J )
11.8), 4.51 (ddd, 1H, J ) 37.0, 7.5, 4.5), 3.74-3.65 (m, 2H); 13C
NMR δ 152.0, 144.3 (d, J ) 13.7), 133.8, 129.4, 128.6, 128.3,
128.1, 127.5, 95.4 (d, J ) 178.1), 86.4, 84.9 (d, J ) 23.4), 73.8,
69.7 (d, J ) 11.3), 49.3 (d, J ) 19.9); 19F NMR δ -174.7 (ddd J
) 54.1, 37.0, 23.6). Anal. Calcd for C23H20N4O2SeFCl: C, 53.35;
H, 3.89; N, 10.82. Found: C, 53.22; H, 4.05; N, 10.80.
12â: Rf 0.31 (C); mp 96-97 °C (EtOH); 1H NMR δ 8.8 (s, 1H),
8.5 (s, 1H), 7.44-6.81 (m, 10H), 7.00 (d, 1H, J ) 9.1), 5.37 (dd,
1H, J ) 52.8, 3.9), 4.70 (d, 1H, J ) 11.3), 4.61 (ddd, 1H, J )
26.1, 2.0, 1.8), 4.59 (d, 1H, J ) 11.3), 4.13 (ddd, 1H, J ) 36.4,
9.1, 3.9), 3.86 (dt, 1H, J ) 10.9, 2.0, 2.0), 3.78 (dd, 1H, 10.9,
1.8); 13C NMR δ 152.0, 146.6, 133.5, 129.0, 128.9, 128.5, 128.1,
95.8 (d, J ) 179.7), 91.2, 83.6 (d, J ) 25.0), 74.0, 69.5 (d, J )
11.8), 50.9 (d, J ) 20.2); 19F NMR δ -178.1 (ddd, J ) 52.8, 36.4,
26.1). Anal. Calcd for C23H20N4O2SeFCl: C, 53.35; H, 3.89; N,
10.82. Found: C, 53.52; H, 4.00; N, 10.71.
12r: Rf 0.2 (C); mp 130-131 °C (EtOH); [R]21 +2.22° (c )
D
1
0.335, CHCl3); H NMR δ 8.87 (s, 1H), 8.61 (s, 1H), 7.38-7.10
Ack n ow led gm en t. This project was carried out
with financial support from DGICYT (Ministerio de
Educacio´n y Ciencia, Spain), Project PB95-0521-A.
N.E.P. thanks CIRIT for a grant. Technical assistance
from the Servei de Recursos Cient´ıfics (Universitat
Rovira i Virgili) is acknowledged.
(m, 11H), 5.39 (dd, 1H, J ) 53.8, 4.7), 4.89 (dt, 1H, J ) 22.7,
2.4, 2.4), 4.58 (ddd, 1H, J ) 37.8, 7.5, 4.7), 4.59 (d, 1H, J ) 11.5),
4.54 (d, 1H, J ) 11.5), 3.76 (d, 2H, J ) 2.4); 13C NMR δ 152.2,
148.3 (d, J ) 11.4), 133.5, 129.4, 128.7, 128.6, 128.4, 128.2, 127.5,
95.4 (d, J ) 179.0), 88.5, 84.8 (d, J ) 23.6), 73.9, 70.1 (d, J )
11.0), 50.6 (d, J ) 19.5); 19F NMR δ -173.7 (ddd, J ) 53.8, 37.8,
22.7). Anal. Calcd for C23H20N4O2SeFCl: C, 53.35; H, 3.89; N,
10.82. Found: C, 53.46; H, 4.03; N, 10.71.
Su p p or tin g In for m a tion Ava ila ble: Experimental de-
scription, figures, and tables of data, details of crystal structure
determinations, bond lengths and angles, and anisotropic
displacement parameters for compounds 11R and 11â. Table
containing selected data of 1H, 13C, and 19NMR spectra of
compounds 11R, 11â, 12R, and 12â and related comments. This
material is available free of charge via the Internet at
http://pubs.acs.org.
1-(5-O-Ben zyl-2,3-d id eoxy-3-flu or o-2-p h en ylselen en yl-
r,â-D-r ibofu r a n osyl)-N3-ben zoylth ym in e (13). Using the gen-
eral glycosylation procedure starting from 0.078 g (0.21 mmol)
of 9 and 0.184 g (0.8 mmol) of N3-benzoylthymine,21 0.073 g (58%)
of 13 was obtained as an R,â mixture: Rf 0.47 (C); 1H NMR δ
6.74 (d, J ) 8.1, H-1R), 6.56 (d, J ) 9.5, H-1â); 19F NMR δ
-173.25 (ddd, J ) 53.9, 40.3, 22.0, F-3â), -179.95 (br m, F-3R).
Gen er a l P r oced u r e for th e Red u ction of 2′-P h en ylsele-
n en yl Nu cleosid es. Tributyltin hydride (0.06 mL, 64.9 mg, 0.22
J O980911F